APO Research

APO RESEARCH · REPORT

Poultry Vaccines

Selected research

Market Outlook & Growth Opportunities

Global Poultry Vaccines Market Outlook and Growth Opportunities 2026

Market perspective

The global Poultry Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poultry Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Poultry Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Poultry Vaccines market include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Poultry Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Poultry Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Poultry Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Poultry Vaccines market.

Poultry Vaccines Segment by Company

Merck

Boehringer Ingelheim

Ceva

Zoetis

Vaxxinova®

Elanco

QYH Biotech Co., Ltd

Pulike

Phibro Animal Health Corporation

JinYu Biotechnology

Harbin Pharmaceutical Group

MEVAC

Venky's

Japfa Comfeed Indonesia

Nisseiken

Hile

Hester Biosciences

Poultry Vaccines Segment by Type

Live

Attenuated

Killed

Poultry Vaccines Segment by Application

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Others

Poultry Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Poultry Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Poultry Vaccines key companies, revenue, market share, and recent developments.

3. To split the Poultry Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Poultry Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Poultry Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Poultry Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poultry Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Poultry Vaccines industry.

Chapter 3: Detailed analysis of Poultry Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Poultry Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Poultry Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Poultry Vaccines Industry Trends Table 2. Poultry Vaccines Industry Drivers Table 3. Poultry Vaccines Industry Opportunities and Challenges Table 4. Poultry Vaccines Industry Restraints Table 5. Global Poultry Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Poultry Vaccines Revenue Share by Company (2021-2026) Table 7. Global Poultry Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Poultry Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Poultry Vaccines Company, Product Type & Application Table 10. Global Poultry Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Poultry Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Live Table 15. Significant Companies of Attenuated Table 16. Significant Companies of Killed Table 17. Global Poultry Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Poultry Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Poultry Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Poultry Vaccines Sales Value Share by Type (2021-2026) Table 21. Global Poultry Vaccines Sales Value Share by Type (2027-2032) Table 22. Significant Companies of NDV Table 23. Significant Companies of Marek ' s Disease Table 24. Significant Companies of IBD Table 25. Significant Companies of Infectious Bronchitis Table 26. Significant Companies of Influenza Table 27. Significant Companies of Others Table 28. Global Poultry Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Poultry Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Poultry Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Poultry Vaccines Sales Value Share by Application (2021-2026) Table 32. Global Poultry Vaccines Sales Value Share by Application (2027-2032) Table 33. Global Poultry Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Poultry Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Poultry Vaccines Sales Value Share by Region (2021-2026) Table 36. Global Poultry Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Poultry Vaccines Sales Value Share by Region (2027-2032) Table 38. Global Poultry Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Poultry Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Poultry Vaccines Sales Value Market Share by Country (2021-2026) Table 41. Global Poultry Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Poultry Vaccines Sales Value Market Share by Country (2027-2032) Table 43. Merck Company Information Table 44. Merck Business Overview Table 45. Merck Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Merck Poultry Vaccines Product Portfolio Table 47. Merck Recent Development Table 48. Boehringer Ingelheim Company Information Table 49. Boehringer Ingelheim Business Overview Table 50. Boehringer Ingelheim Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Boehringer Ingelheim Poultry Vaccines Product Portfolio Table 52. Boehringer Ingelheim Recent Development Table 53. Ceva Company Information Table 54. Ceva Business Overview Table 55. Ceva Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Ceva Poultry Vaccines Product Portfolio Table 57. Ceva Recent Development Table 58. Zoetis Company Information Table 59. Zoetis Business Overview Table 60. Zoetis Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Zoetis Poultry Vaccines Product Portfolio Table 62. Zoetis Recent Development Table 63. Vaxxinova® Company Information Table 64. Vaxxinova® Business Overview Table 65. Vaxxinova® Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Vaxxinova® Poultry Vaccines Product Portfolio Table 67. Vaxxinova® Recent Development Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Elanco Poultry Vaccines Product Portfolio Table 72. Elanco Recent Development Table 73. QYH Biotech Co., Ltd Company Information Table 74. QYH Biotech Co., Ltd Business Overview Table 75. QYH Biotech Co., Ltd Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio Table 77. QYH Biotech Co., Ltd Recent Development Table 78. Pulike Company Information Table 79. Pulike Business Overview Table 80. Pulike Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pulike Poultry Vaccines Product Portfolio Table 82. Pulike Recent Development Table 83. Phibro Animal Health Corporation Company Information Table 84. Phibro Animal Health Corporation Business Overview Table 85. Phibro Animal Health Corporation Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Phibro Animal Health Corporation Poultry Vaccines Product Portfolio Table 87. Phibro Animal Health Corporation Recent Development Table 88. JinYu Biotechnology Company Information Table 89. JinYu Biotechnology Business Overview Table 90. JinYu Biotechnology Poultry Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. JinYu Biotechnology Poultry Vaccines Product Portfolio Table 92. JinYu Biotechnology Recent Development Table 93. Harbin Pharmaceutical Group Company Information Table 94. Harbin Pharmaceutical Group Business Overview Table 95. Harbin Pharmaceutical Group Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio Table 97. Harbin Pharmaceutical Group Recent Development Table 98. MEVAC Company Information Table 99. MEVAC Business Overview Table 100. MEVAC Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. MEVAC Poultry Vaccines Product Portfolio Table 102. MEVAC Recent Development Table 103. Venky's Company Information Table 104. Venky's Business Overview Table 105. Venky's Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Venky's Poultry Vaccines Product Portfolio Table 107. Venky's Recent Development Table 108. Japfa Comfeed Indonesia Company Information Table 109. Japfa Comfeed Indonesia Business Overview Table 110. Japfa Comfeed Indonesia Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio Table 112. Japfa Comfeed Indonesia Recent Development Table 113. Nisseiken Company Information Table 114. Nisseiken Business Overview Table 115. Nisseiken Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Nisseiken Poultry Vaccines Product Portfolio Table 117. Nisseiken Recent Development Table 118. Hile Company Information Table 119. Hile Business Overview Table 120. Hile Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hile Poultry Vaccines Product Portfolio Table 122. Hile Recent Development Table 123. Hester Biosciences Company Information Table 124. Hester Biosciences Business Overview Table 125. Hester Biosciences Poultry Vaccines Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Hester Biosciences Poultry Vaccines Product Portfolio Table 127. Hester Biosciences Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Poultry Vaccines Product Image Figure 2. Global Poultry Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poultry Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Poultry Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Live Image Figure 8. Attenuated Image Figure 9. Killed Image Figure 10. Global Poultry Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Poultry Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Poultry Vaccines Sales Value Share by Type (2021-2032) Figure 13. NDV Image Figure 14. Marek ' s Disease Image Figure 15. IBD Image Figure 16. Infectious Bronchitis Image Figure 17. Influenza Image Figure 18. Others Image Figure 19. Global Poultry Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Poultry Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Poultry Vaccines Sales Value Share by Application (2021-2032) Figure 22. Global Poultry Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Poultry Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Poultry Vaccines Sales Value (2021-2032) & (US$ Million) Figure 25. North America Poultry Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Poultry Vaccines Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Poultry Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Poultry Vaccines Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Poultry Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Poultry Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. South America Poultry Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Poultry Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Poultry Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Poultry Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Poultry Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Poultry Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Attenuated
  • Killed
Applications
  • NDV
  • Marek ' s Disease
  • IBD
  • Infectious Bronchitis
  • Influenza
  • Others
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Ceva
  • Zoetis
  • Vaxxinova®
  • Elanco
  • QYH Biotech Co., Ltd
  • Pulike
  • Phibro Animal Health Corporation
  • JinYu Biotechnology
  • Harbin Pharmaceutical Group
  • MEVAC
  • Venky's
  • Japfa Comfeed Indonesia
  • Nisseiken
  • Hile
  • Hester Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Poultry Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Poultry Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Poultry Vaccines Market Dynamics
  1. 2.1 Poultry Vaccines Industry Trends
  2. 2.2 Poultry Vaccines Industry Drivers
  3. 2.3 Poultry Vaccines Industry Opportunities and Challenges
  4. 2.4 Poultry Vaccines Industry Restraints
3 Poultry Vaccines Market by Company
  1. 3.1 Global Poultry Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Poultry Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Poultry Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Poultry Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Poultry Vaccines Company Product Type and Application
  6. 3.6 Global Poultry Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Poultry Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Poultry Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Poultry Vaccines Market by Type
  1. 4.1 Poultry Vaccines Type Introduction
  2. 4.1.1 Live
  3. 4.1.2 Attenuated
  4. 4.1.3 Killed
  5. 4.2 Global Poultry Vaccines Sales Value by Type
  6. 4.2.1 Global Poultry Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Poultry Vaccines Sales Value by Type (2021-2032)
  8. 4.2.3 Global Poultry Vaccines Sales Value Share by Type (2021-2032)
5 Poultry Vaccines Market by Application
  1. 5.1 Poultry Vaccines Application Introduction
  2. 5.1.1 NDV
  3. 5.1.2 Marek ' s Disease
  4. 5.1.3 IBD
  5. 5.1.4 Infectious Bronchitis
  6. 5.1.5 Influenza
  7. 5.1.6 Others
  8. 5.2 Global Poultry Vaccines Sales Value by Application
  9. 5.2.1 Global Poultry Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Poultry Vaccines Sales Value by Application (2021-2032)
  11. 5.2.3 Global Poultry Vaccines Sales Value Share by Application (2021-2032)
6 Poultry Vaccines Regional Value Analysis
  1. 6.1 Global Poultry Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Poultry Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Poultry Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Poultry Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Poultry Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Poultry Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Poultry Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Poultry Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Poultry Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Poultry Vaccines Sales Value Share by Country, 2025 VS 2032
7 Poultry Vaccines Country-level Value Analysis
  1. 7.1 Global Poultry Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Poultry Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Poultry Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Poultry Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Poultry Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Poultry Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Poultry Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Poultry Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Poultry Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Poultry Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Poultry Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Poultry Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Poultry Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Poultry Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Poultry Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Poultry Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Poultry Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Poultry Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Poultry Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Poultry Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Poultry Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Poultry Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Poultry Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Poultry Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Poultry Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Poultry Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Poultry Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Poultry Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Poultry Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Poultry Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Poultry Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Poultry Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Poultry Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Poultry Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Poultry Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Poultry Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Poultry Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Poultry Vaccines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Ceva
  14. 8.3.1 Ceva Company Information
  15. 8.3.2 Ceva Business Overview
  16. 8.3.3 Ceva Poultry Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Poultry Vaccines Product Portfolio
  18. 8.3.5 Ceva Recent Developments
  19. 8.4 Zoetis
  20. 8.4.1 Zoetis Company Information
  21. 8.4.2 Zoetis Business Overview
  22. 8.4.3 Zoetis Poultry Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zoetis Poultry Vaccines Product Portfolio
  24. 8.4.5 Zoetis Recent Developments
  25. 8.5 Vaxxinova®
  26. 8.5.1 Vaxxinova® Company Information
  27. 8.5.2 Vaxxinova® Business Overview
  28. 8.5.3 Vaxxinova® Poultry Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vaxxinova® Poultry Vaccines Product Portfolio
  30. 8.5.5 Vaxxinova® Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Poultry Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Poultry Vaccines Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 QYH Biotech Co., Ltd
  38. 8.7.1 QYH Biotech Co., Ltd Company Information
  39. 8.7.2 QYH Biotech Co., Ltd Business Overview
  40. 8.7.3 QYH Biotech Co., Ltd Poultry Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio
  42. 8.7.5 QYH Biotech Co., Ltd Recent Developments
  43. 8.8 Pulike
  44. 8.8.1 Pulike Company Information
  45. 8.8.2 Pulike Business Overview
  46. 8.8.3 Pulike Poultry Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pulike Poultry Vaccines Product Portfolio
  48. 8.8.5 Pulike Recent Developments
  49. 8.9 Phibro Animal Health Corporation
  50. 8.9.1 Phibro Animal Health Corporation Company Information
  51. 8.9.2 Phibro Animal Health Corporation Business Overview
  52. 8.9.3 Phibro Animal Health Corporation Poultry Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Phibro Animal Health Corporation Poultry Vaccines Product Portfolio
  54. 8.9.5 Phibro Animal Health Corporation Recent Developments
  55. 8.10 JinYu Biotechnology
  56. 8.10.1 JinYu Biotechnology Company Information
  57. 8.10.2 JinYu Biotechnology Business Overview
  58. 8.10.3 JinYu Biotechnology Poultry Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JinYu Biotechnology Poultry Vaccines Product Portfolio
  60. 8.10.5 JinYu Biotechnology Recent Developments
  61. 8.11 Harbin Pharmaceutical Group
  62. 8.11.1 Harbin Pharmaceutical Group Company Information
  63. 8.11.2 Harbin Pharmaceutical Group Business Overview
  64. 8.11.3 Harbin Pharmaceutical Group Poultry Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio
  66. 8.11.5 Harbin Pharmaceutical Group Recent Developments
  67. 8.12 MEVAC
  68. 8.12.1 MEVAC Company Information
  69. 8.12.2 MEVAC Business Overview
  70. 8.12.3 MEVAC Poultry Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MEVAC Poultry Vaccines Product Portfolio
  72. 8.12.5 MEVAC Recent Developments
  73. 8.13 Venky's
  74. 8.13.1 Venky's Company Information
  75. 8.13.2 Venky's Business Overview
  76. 8.13.3 Venky's Poultry Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Venky's Poultry Vaccines Product Portfolio
  78. 8.13.5 Venky's Recent Developments
  79. 8.14 Japfa Comfeed Indonesia
  80. 8.14.1 Japfa Comfeed Indonesia Company Information
  81. 8.14.2 Japfa Comfeed Indonesia Business Overview
  82. 8.14.3 Japfa Comfeed Indonesia Poultry Vaccines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio
  84. 8.14.5 Japfa Comfeed Indonesia Recent Developments
  85. 8.15 Nisseiken
  86. 8.15.1 Nisseiken Company Information
  87. 8.15.2 Nisseiken Business Overview
  88. 8.15.3 Nisseiken Poultry Vaccines Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nisseiken Poultry Vaccines Product Portfolio
  90. 8.15.5 Nisseiken Recent Developments
  91. 8.16 Hile
  92. 8.16.1 Hile Company Information
  93. 8.16.2 Hile Business Overview
  94. 8.16.3 Hile Poultry Vaccines Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hile Poultry Vaccines Product Portfolio
  96. 8.16.5 Hile Recent Developments
  97. 8.17 Hester Biosciences
  98. 8.17.1 Hester Biosciences Company Information
  99. 8.17.2 Hester Biosciences Business Overview
  100. 8.17.3 Hester Biosciences Poultry Vaccines Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hester Biosciences Poultry Vaccines Product Portfolio
  102. 8.17.5 Hester Biosciences Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research